Literature DB >> 1662508

Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?

D A Gewirtz1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1662508     DOI： 10.1016/0006-2952(91)90227-v

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  9 in total

Review 1.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group.

Authors:  J A Ross; J D Potter; G H Reaman; T W Pendergrass; L L Robison
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

3.  Induction of apoptosis in human cancer cell lines by the novel anthracenyl-amino acid topoisomerase I inhibitor NU/ICRF 505.

Authors:  I Meikle; J Cummings; J S Macpherson; J F Smyth
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

4.  Formation of adriamycin--DNA adducts in vitro.

Authors:  C Cullinane; S M Cutts; A van Rosmalen; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

5.  Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.

Authors:  M C Bissery; C H Nguyen; E Bisagni; P Vrignaud; F Lavelle
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

6.  Toxicological aspects of the use of phenolic compounds in disease prevention.

Authors:  Zuzana Kyselova
Journal:  Interdiscip Toxicol       Date:  2011-12

7.  Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide.

Authors:  T Asano; L A Zwelling; T An; A McWatters; C E Herzog; J Mayes; S M Loughlin; E S Kleinerman
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

8.  Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells.

Authors:  A M E Bruynzeel; M A Abou El Hassan; E Torun; A Bast; W J F van der Vijgh; F A E Kruyt
Journal:  Br J Cancer       Date:  2007-02-12       Impact factor: 7.640

9.  Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.

Authors:  M Inaba; J Mitsuhashi; S Kawada; H Nakano
Journal:  Jpn J Cancer Res       Date:  1994-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.